Working Papers

March 1, 2002

Working Papers

Using Litigation To Regulate Drug Prices: The Assault on “AWP”

Download the PDF

By James M. Spears, a partner, and Jeff Pearlman, an associate, respectively, in the Washington, D.C. office of the law firm Ropes & Gray.

Related Content

Legal Backgrounders

November 2, 2001

FTC Improperly Injects Itself Into Drug Patent Settlements

By Geraldine M. Alexis and Zorah Braithwaite, with the law firm McCutchen, Doyle, Brown & Enersen, LLP in its San Francisco office.

Working Papers

November 1, 2001

Enhancing World Health Through Global Protection Of Drug Patent Rights

By Richard Wilder, a partner in the Washington, D.C. office of the law firm Powell, Goldstein, Frazer & Murphy.

Legal Backgrounders

July 13, 2001

Drug Patent Settlements Should Be Handled On A Case By Case Basis

By Jeffrey I. Weinberger, a partner with Munger, Tolles & Olson LLP in Los Angeles, specializing in antitrust and trade regulation matters, and the Chair-Elect of the Antitrust and Unfair Competition Law Section of the State Bar of California.